- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05446220
Twelve-year Follow-up on the Treatment of Obese Pregnant Women (TOP) Study (TOP12)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The initial study (Treatment of Obese Pregnant women (TOP) study) was performed at Hvidovre Hospital, University of Copenhagen in 2009-12 and included 425 pregnant women with pre-gestational BMI ≥ 30kg/m2 in gestational week 11-14. They were randomized 1:1:1 into: 1) a low-calorie Mediterranean-style diet and pedometer assisted physical activity (PA) intervention 2) a pedometer assisted PA intervention alone or 3) no intervention (control). Primary outcome was gestational weight gain (GWG). 389 women completed the study.
The participants (both mother and child in pair) who completed the initial TOP study will be invited to a 3-hour examination now 12 years after the intervention during pregnancy to evaluate the effect of the intervention on both mother and child long term.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Herlev, Denmark, 2730
- Steno Diabetes Center Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants/mothers in the initial TOP study will be invited with their offspring born following the pregnancy during the initial study to the 12-year follow-up study
Exclusion Criteria:
- There are no exclusion criteria as the potential study population has already been selected at the baseline study in 2009-2012
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
No intervention
|
|
|
Experimental: Diet + physical activity
Dietary advise and advise on physical activity monitored by pedometer
|
Dietary advise and/or advise on physical activity monitored by pedometer
|
|
Experimental: Physical activity
Advise on physical activity monitored by pedometer
|
Dietary advise and/or advise on physical activity monitored by pedometer
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition
Time Frame: 2 years data collection
|
Fatt mass index offspring, DXA scan + BMI mothers
|
2 years data collection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metabolic and inflammatory markers
Time Frame: 2 years data collection
|
Analyses of blood samples
|
2 years data collection
|
|
Glycemic variability
Time Frame: 2 years data collection
|
CGM measures
|
2 years data collection
|
|
Mental health
Time Frame: 2 years data collection
|
Assessed by questionnaires, validated to mother and child respectively
|
2 years data collection
|
|
Diet composition
Time Frame: 2 years data collection
|
Assessed by FFQ (food frequency questionnaire), validated to mother and child respectively
|
2 years data collection
|
|
Epigenetic examinations
Time Frame: 2 years data collection
|
Epigenetic examinations
|
2 years data collection
|
|
Liver stiffness
Time Frame: 2 years data collection
|
FibroScan
|
2 years data collection
|
|
Large artery stiffness
Time Frame: 2 years data collection
|
SphygmoCor examination
|
2 years data collection
|
|
Eye examination
Time Frame: 2 years data collection
|
OPTOS
|
2 years data collection
|
|
Sex hormones
Time Frame: 2 years data collection
|
Analyses of blood samples, children
|
2 years data collection
|
|
Puberty stage
Time Frame: 2 years data collection
|
According to the classifications of Marshall and Tanner
|
2 years data collection
|
|
Blood pressure
Time Frame: 2 years data collection
|
Standardized sitting measurement of systolic and diastolic blood pressure, average of 3 measures
|
2 years data collection
|
|
Level and pattern of physical activity
Time Frame: 2 years data collection
|
Assessed by activity tracker worn on the rist for 7 days + IPAQ short (International physical activity questionnaire)
|
2 years data collection
|
|
Relative fitness level
Time Frame: 2 years data collection
|
Estimated relative fitness level assessed by a submaximal step test (The Danish Step Test)
|
2 years data collection
|
|
Lung function
Time Frame: 2 years data collection
|
Spirometry assessing FVC and FEV1
|
2 years data collection
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kristina M Renault, Rigshospitalet, Denmark
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TOP12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.